S&P 500   3,993.10 (+0.33%)
DOW   31,670.35 (+0.28%)
QQQ   298.72 (-0.08%)
AAPL   154.86 (-0.71%)
MSFT   257.89 (-0.08%)
META   160.03 (-0.22%)
GOOGL   108.67 (-0.71%)
AMZN   128.64 (-0.65%)
TSLA   285.64 (+0.68%)
NVDA   137.57 (+0.31%)
NIO   17.39 (-0.51%)
BABA   89.48 (-1.24%)
AMD   81.63 (+2.54%)
T   16.83 (-0.24%)
MU   54.62 (-0.69%)
CGC   3.40 (-0.29%)
F   15.19 (-1.56%)
GE   73.37 (-0.29%)
DIS   111.92 (-0.68%)
AMC   8.61 (+2.62%)
PYPL   95.22 (+0.26%)
PFE   46.66 (+1.15%)
NFLX   224.78 (-1.83%)
S&P 500   3,993.10 (+0.33%)
DOW   31,670.35 (+0.28%)
QQQ   298.72 (-0.08%)
AAPL   154.86 (-0.71%)
MSFT   257.89 (-0.08%)
META   160.03 (-0.22%)
GOOGL   108.67 (-0.71%)
AMZN   128.64 (-0.65%)
TSLA   285.64 (+0.68%)
NVDA   137.57 (+0.31%)
NIO   17.39 (-0.51%)
BABA   89.48 (-1.24%)
AMD   81.63 (+2.54%)
T   16.83 (-0.24%)
MU   54.62 (-0.69%)
CGC   3.40 (-0.29%)
F   15.19 (-1.56%)
GE   73.37 (-0.29%)
DIS   111.92 (-0.68%)
AMC   8.61 (+2.62%)
PYPL   95.22 (+0.26%)
PFE   46.66 (+1.15%)
NFLX   224.78 (-1.83%)
S&P 500   3,993.10 (+0.33%)
DOW   31,670.35 (+0.28%)
QQQ   298.72 (-0.08%)
AAPL   154.86 (-0.71%)
MSFT   257.89 (-0.08%)
META   160.03 (-0.22%)
GOOGL   108.67 (-0.71%)
AMZN   128.64 (-0.65%)
TSLA   285.64 (+0.68%)
NVDA   137.57 (+0.31%)
NIO   17.39 (-0.51%)
BABA   89.48 (-1.24%)
AMD   81.63 (+2.54%)
T   16.83 (-0.24%)
MU   54.62 (-0.69%)
CGC   3.40 (-0.29%)
F   15.19 (-1.56%)
GE   73.37 (-0.29%)
DIS   111.92 (-0.68%)
AMC   8.61 (+2.62%)
PYPL   95.22 (+0.26%)
PFE   46.66 (+1.15%)
NFLX   224.78 (-1.83%)
S&P 500   3,993.10 (+0.33%)
DOW   31,670.35 (+0.28%)
QQQ   298.72 (-0.08%)
AAPL   154.86 (-0.71%)
MSFT   257.89 (-0.08%)
META   160.03 (-0.22%)
GOOGL   108.67 (-0.71%)
AMZN   128.64 (-0.65%)
TSLA   285.64 (+0.68%)
NVDA   137.57 (+0.31%)
NIO   17.39 (-0.51%)
BABA   89.48 (-1.24%)
AMD   81.63 (+2.54%)
T   16.83 (-0.24%)
MU   54.62 (-0.69%)
CGC   3.40 (-0.29%)
F   15.19 (-1.56%)
GE   73.37 (-0.29%)
DIS   111.92 (-0.68%)
AMC   8.61 (+2.62%)
PYPL   95.22 (+0.26%)
PFE   46.66 (+1.15%)
NFLX   224.78 (-1.83%)
Top-Rated Stocks  
NYSE:BSX

Boston Scientific - BSX Stock Forecast, Price & News

$42.08
+0.61 (+1.47%)
(As of 09/8/2022 10:34 AM ET)
Add
Compare
Today's Range
$41.14
▼
$42.12
50-Day Range
$36.71
▼
$42.63
52-Week Range
$34.98
▼
$47.49
Volume
58,230 shs
Average Volume
5.39 million shs
Market Capitalization
$60.16 billion
P/E Ratio
72.55
Dividend Yield
N/A
Price Target
$46.55

Boston Scientific MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
12.2% Upside
$46.55 Price Target
Short Interest
Healthy
1.18% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.88
Upright™ Environmental Score
News Sentiment
0.49mentions of Boston Scientific in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$2.40 M Sold Last Quarter
Proj. Earnings Growth
11.36%
From $1.76 to $1.96 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

Medical Sector

73rd out of 1,091 stocks

Surgical & Medical Instruments Industry

11th out of 105 stocks

See Top Rated MarketRank™ Stocks Here
BSX stock logo

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Stock News Headlines

September 6, 2022 | markets.businessinsider.com
Boston Scientific Gets FDA Approval For Expanded Labeling Of WATCHMAN FLX LAAC Device
September 6, 2022 | finance.yahoo.com
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
September 2, 2022 | nasdaq.com
Investing in Boston Scientific (NYSE:BSX) five years ago would have delivered you a 44% gain
September 1, 2022 | nasdaq.com
Interesting BSX Put And Call Options For October 14th
August 31, 2022 | americanbankingnews.com
Head to Head Survey: AtriCure (NASDAQ:ATRC) & Boston Scientific (NYSE:BSX)
August 31, 2022 | americanbankingnews.com
Head to Head Contrast: AtriCure (NASDAQ:ATRC) vs. Boston Scientific (NYSE:BSX)
August 29, 2022 | finance.yahoo.com
Billionaire Izzy Englander’s Latest Portfolio: Top 10 Stock Picks
August 28, 2022 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Lifted to B- at TheStreet
August 27, 2022 | americanbankingnews.com
Reviewing Boston Scientific (NYSE:BSX) & PetVivo (OTCMKTS:PETV)
August 26, 2022 | nasdaq.com
Interesting BSX Put And Call Options For October 7th
August 25, 2022 | nasdaq.com
Bullish Two Hundred Day Moving Average Cross - BSX
August 25, 2022 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) Receives $46.55 Average Target Price from Analysts
August 22, 2022 | finance.yahoo.com
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
August 17, 2022 | finance.yahoo.com
Boston Scientific Named a Best Place To Work by Disability:IN
August 17, 2022 | finance.yahoo.com
Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement
August 16, 2022 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) EVP Wendy Carruthers Sells 7,500 Shares of Stock
August 15, 2022 | benzinga.com
Boston Scientific Adds 'Novel' Technology Via This Acquisition For Interventional Oncology
August 15, 2022 | finance.yahoo.com
Boston Scientific Announces Acquisition of Obsidio, Inc.
August 12, 2022 | nasdaq.com
This Insider Has Just Sold Shares In Boston Scientific Corporation (NYSE:BSX)
August 9, 2022 | seekingalpha.com
Boston Scientific: Strong Earnings Report, But Shares Are Not Cheap Yet
August 8, 2022 | finance.yahoo.com
Boston Scientific Recognized by Seramount's Best Companies for Multicultural Women
August 8, 2022 | finance.yahoo.com
Boston Scientific Investigates Whistleblower Report in Vietnam
August 2, 2022 | markets.businessinsider.com
Nevro And Boston Scientific Reach $85 Mln Settlement Of Ongoing Intellectual Property Litigations
July 27, 2022 | fool.com
Boston Scientific (BSX) Q2 2022 Earnings Call Transcript
July 27, 2022 | seekingalpha.com
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q2 2022 Results - Earnings Call Transcript
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings
7/27/2022
Today
9/08/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BSX
CUSIP
10113710
CIK
885725
Web
www.bostonscientific.com
Phone
(508) 683-4000
Fax
508-683-5675
Employees
41,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$46.55
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+10.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.58
Trailing P/E Ratio
72.55
Forward P/E Ratio
23.91
P/E Growth
2.19
Net Income
$1.04 billion
Net Margins
7.16%
Pretax Margin
8.95%
Return on Equity
14.58%
Return on Assets
7.60%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
1.31
Quick Ratio
0.86

Sales & Book Value

Annual Sales
$11.89 billion
Price / Sales
5.06
Cash Flow
$2.82 per share
Price / Cash Flow
14.93
Book Value
$11.66 per share
Price / Book
3.61

Miscellaneous

Outstanding Shares
1,429,570,000
Free Float
1,419,421,000
Market Cap
$60.16 billion
Optionable
Optionable
Beta
0.85

Social Links


Key Executives

  • Mr. Michael F. MahoneyMr. Michael F. Mahoney (Age 57)
    Chairman, Pres & CEO
    Comp: $3.83M
  • Mr. Daniel J. BrennanMr. Daniel J. Brennan (Age 56)
    Exec. VP & CFO
    Comp: $1.4M
  • Mr. Joseph M. Fitzgerald (Age 58)
    Exec. VP & Group Pres of Cardiology
    Comp: $1.57M
  • Mr. Jeffrey B. MirvissMr. Jeffrey B. Mirviss (Age 56)
    Exec. VP & Pres of Peripheral Interventions
    Comp: $1.21M
  • Mr. John Bradley SorensonMr. John Bradley Sorenson (Age 54)
    Exec. VP of Global Operations
  • Mr. Jonathan R MonsonMr. Jonathan R Monson
    VP, Global Controller & Chief Accounting Officer
  • Ms. Jodi Euerle EddyMs. Jodi Euerle Eddy (Age 49)
    Sr. VP and Chief Information & Digital Officer
  • Ms. Susan Vissers Lisa (Age 53)
    VP of Investor Relations
  • Mr. Vance R. Brown
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Ms. Catherine Jennings
    VP of Global Marketing & New Bus. Devel. of Peripheral Interventions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.

What is Boston Scientific's stock price forecast for 2022?

12 brokerages have issued 1 year target prices for Boston Scientific's shares. Their BSX share price forecasts range from $43.00 to $51.00. On average, they anticipate the company's stock price to reach $46.55 in the next year. This suggests a possible upside of 12.2% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2022?

Boston Scientific's stock was trading at $42.48 at the beginning of the year. Since then, BSX shares have decreased by 2.4% and is now trading at $41.47.
View the best growth stocks for 2022 here.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 16,860,000 shares, an increase of 22.6% from the July 31st total of 13,750,000 shares. Based on an average daily trading volume, of 7,510,000 shares, the days-to-cover ratio is currently 2.2 days.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our BSX earnings forecast.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) announced its earnings results on Wednesday, July, 27th. The medical equipment provider reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.02. The medical equipment provider earned $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Boston Scientific had a net margin of 7.16% and a trailing twelve-month return on equity of 14.58%. Boston Scientific's revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.40 earnings per share.
Read the conference call transcript.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $0.43-$0.45 for the period, compared to the consensus earnings per share estimate of $0.45. The company issued revenue guidance of $3.11 billion-$3.17 billion, compared to the consensus revenue estimate of $3.20 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a variety of institutional and retail investors. Top institutional investors include Primecap Management Co. CA (2.65%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (1.46%), Artisan Partners Limited Partnership (1.35%), Parnassus Investments LLC (1.10%), Northern Trust Corp (0.97%) and Lazard Asset Management LLC (0.89%). Insiders that own company stock include Arthur C Butcher, Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Wendy Carruthers, William F Bruss and Williamson Scott.
View institutional ownership trends.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $41.47.

How much money does Boston Scientific make?

Boston Scientific (NYSE:BSX) has a market capitalization of $59.28 billion and generates $11.89 billion in revenue each year. The medical equipment provider earns $1.04 billion in net income (profit) each year or $0.58 on an earnings per share basis.

How many employees does Boston Scientific have?

The company employs 41,000 workers across the globe.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
When was Boston Scientific founded?

Boston Scientific was founded in 1979.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.